Breast Cancer Stem Cell–Derived Tumors Escape from γδ T-cell Immunosurveillance In Vivo by Modulating γδ T-cell Ligands

There are no targeted therapies for patients with triple-negative breast cancer (TNBC). TNBC is enriched in breast cancer stem cells (BCSC), which play a key role in metastasis, chemoresistance, relapse, and mortality. γδ T cells hold great potential in immunotherapy against cancer and might provide...

Descripción completa

Detalles Bibliográficos
Autores principales: Raute, Katrin, Strietz, Juliane, Parigiani, Maria Alejandra, Andrieux, Geoffroy, Thomas, Oliver S., Kistner, Klaus M., Zintchenko, Marina, Aichele, Peter, Hofmann, Maike, Zhou, Houjiang, Weber, Wilfried, Boerries, Melanie, Swamy, Mahima, Maurer, Jochen, Minguet, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236150/
https://www.ncbi.nlm.nih.gov/pubmed/37139603
http://dx.doi.org/10.1158/2326-6066.CIR-22-0296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236150/
https://www.ncbi.nlm.nih.gov/pubmed/37139603
http://dx.doi.org/10.1158/2326-6066.CIR-22-0296

Ejemplares similares